We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

Scancell

Successful upsized placing raises over £10m

Lighthouse | 01 December 2023

Arecor Therapeutics

Appreciating a well-executed development strategy

Outlook | 30 November 2023

Arecor Therapeutics

AT220 European launch marks first Arestat success

Lighthouse | 17 November 2023

HUTCHMED

Landmark FDA approval for fruquintinib

Lighthouse | 13 November 2023

ANGLE

Moving in the right direction to capture growth

Lighthouse | 10 November 2023

Scancell

Business update and FY23 results

Lighthouse | 31 October 2023

Redx Pharma

New funds provide runway through 2024 catalysts

Lighthouse | 18 October 2023

Avacta

Momentum builds in Diagnostics and Therapeutics

Lighthouse | 28 September 2023

Scancell

SCIB1 SCOPE study shows a striking 82% ORR

Lighthouse | 19 September 2023

Futura Medical

Significant achievements position MED3000 for success

Outlook | 18 September 2023
1 2 3 4 5 6 7 8 9 10 >
397 results found.